Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction - Scorecard - MDSpire
Advertisement
Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction
Clinical Scorecard: Link Between Remnant Cholesterol Inflammatory Index and New-Onset Atrial Fibrillation During Hospitalization in ST-Segment Elevation Myocardial Infarction Patients
At a Glance
Category
Detail
Condition
New-onset atrial fibrillation (NOAF)
Key Mechanisms
Remnant cholesterol inflammatory index (RCII) integrates lipid metabolism abnormalities and systemic inflammation.
Target Population
Patients with acute ST-segment elevation myocardial infarction (STEMI).
Care Setting
In-hospital setting during acute STEMI management.
Key Highlights
8.36% of STEMI patients developed NOAF during hospitalization.
Higher levels of RCII, RC, and hs-CRP were observed in patients with NOAF.
RCII showed moderate discriminatory ability for identifying NOAF risk.
Multivariable analysis indicated RCII as an independent predictor of NOAF.
RCII may serve as a cost-effective early risk stratification tool.
Guideline-Based Recommendations
Diagnosis
Monitor for new-onset atrial fibrillation in STEMI patients.
Management
Consider RCII as a risk stratification tool for NOAF in STEMI patients.
Monitoring & Follow-up
Continuous electrocardiographic monitoring for at least 72 hours post-PCI.
Risks
NOAF is associated with increased risk of mortality, heart failure, and stroke.
Patient & Prescribing Data
Patients hospitalized with first-time acute STEMI.
Emergency percutaneous coronary intervention (PCI) is a standard treatment.
Clinical Best Practices
Utilize RCII for early identification of patients at high risk for NOAF.
Integrate lipid and inflammatory markers in risk assessment.
